Jean Sibilia focuses on Internal medicine, Surgery, Rheumatoid arthritis, Gastroenterology and Immunology. His study in Rheumatology, Randomized controlled trial, Prospective cohort study, Adverse effect and Rituximab are all subfields of Internal medicine. His Surgery study combines topics in areas such as Pulmonary hypertension, Adalimumab, Tocilizumab and Infliximab.
The study incorporates disciplines such as Physical therapy, Rheumatism and Arthritis in addition to Rheumatoid arthritis. His studies in Gastroenterology integrate themes in fields like Scleroderma, Lupus nephritis, Lymphoma and Interstitial lung disease. His biological study spans a wide range of topics, including Odds ratio, Allele and Genetic predisposition.
Jean Sibilia mainly investigates Internal medicine, Rheumatoid arthritis, Immunology, Surgery and Arthritis. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Physical therapy. His Rheumatoid arthritis research is multidisciplinary, incorporating perspectives in Methotrexate and Abatacept, Rituximab.
His Immunology study is mostly concerned with Autoimmune disease, Autoantibody, Antibody, Autoimmunity and Connective tissue disease. His Autoimmune disease study combines topics from a wide range of disciplines, such as Systemic disease and Immunopathology. His biological study spans a wide range of topics, including Etanercept and Infliximab.
Internal medicine, Rheumatoid arthritis, Immunology, Cohort and Disease are his primary areas of study. Internal medicine is often connected to Gastroenterology in his work. His research in Rheumatoid arthritis intersects with topics in Odds ratio, Discontinuation, Abatacept and Arthritis.
His research investigates the connection between Cohort and topics such as Systemic lupus erythematosus that intersect with problems in Lupus erythematosus, Adverse effect and Pharmacovigilance. His Disease study also includes
His scientific interests lie mostly in Internal medicine, Immunology, Rheumatoid arthritis, Rituximab and Systemic lupus erythematosus. His study connects Case-control study and Immunology. His Rheumatoid arthritis research incorporates elements of Interstitial lung disease and Arthritis.
In his work, Gastroenterology is strongly intertwined with Risk factor, which is a subfield of Arthritis. His Rituximab research incorporates themes from Belimumab, Randomized controlled trial, Discontinuation and Cyclophosphamide. Jean Sibilia interconnects Adalimumab, Pharmacovigilance, Adverse drug reaction, Infliximab and Etanercept in the investigation of issues within Systemic lupus erythematosus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.
Eric Hachulla;Virginie Gressin;Loïc Guillevin;Patrick Carpentier.
Arthritis & Rheumatism (2005)
Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage
O Meyer;C Labarre;M Dougados;Ph Goupille.
Annals of the Rheumatic Diseases (2003)
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome
Jacques-Eric Gottenberg;Nicolas Cagnard;Carlo Lucchesi;Franck Letourneur.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept - Twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial
Joel J.M. Kremer;Maxime Dougados;Paul Emery;Patrick Durez.
Arthritis & Rheumatism (2005)
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
Hélène Chifflot;Bruno Fautrel;Christelle Sordet;Emmanuel Chatelus.
Seminars in Arthritis and Rheumatism (2008)
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
Xavier Mariette;Philippe Ravaud;Serge Steinfeld;Gabriel Baron.
Arthritis & Rheumatism (2004)
Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases
JE Gottenberg;L Guillevin;O Lambotte;B Combe.
Annals of the Rheumatic Diseases (2005)
Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France
Xavier Mariette;Dominique Cazals-Hatem;Josiane Warszawki;Frédéric Liote.
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics and treatments in the QUEST-RA study
Tuulikki Sokka;Sergio Toloza;Maurizio Cutolo;Hannu Kautiainen.
Arthritis Research & Therapy (2009)
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type
Pierre Quartier;Pierre Taupin;Franck Bourdeaut;Irène Lemelle.
Arthritis & Rheumatism (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: